[Variability of N in Meniere's disease].
Intratympanic treatment of incapacitating vertigo in Menière's disease has become a first option treatment for most otolaryngologists nowadays. Reporting their results following adequate minimum follow-up and under the same criteria is as important as to clearly state the indications that have been settled, through adequate handicap psychometric tests. Furthermore, when results are reported, knowing the total number of patients (N) with a diagnosis of Menière's disease is essential to evaluate such results in those treated patients, bearing in mind that most Menière's patients do well with medical treatment as well.
Plaza
G
G
Denia
A
A
de los Santos
G
G
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy* / Q000453:epidemiology*; D014432:Tympanic Membrane
D000900:Anti-Bacterial Agents; D005839:Gentamicins
Variabilidad del N en la enfermedad de Ménière.